Anixa Biosciences (ANIX) Liabilities and Shareholders Equity (2010 - 2026)
Anixa Biosciences' Liabilities and Shareholders Equity was $15.07 million in fiscal Q3 2026 (quarter ended Jul 31, 2026), down 14.6% from $17.65 million a year earlier but up 1.4% from the prior quarter.
Powered by 
Analysis
Anixa Biosciences (ANIX) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
At the end of FY2025 (ended Oct 31, 2025), Liabilities and Shareholders Equity at Anixa Biosciences came in at $16.08 million, down 25.5% from FY2024.
- Liabilities and Shareholders Equity has now declined for four consecutive fiscal years, though with a five-year compound annual growth rate of 11.2% (FY2020 to FY2025).
- In earlier fiscal years, Liabilities and Shareholders Equity was $21.59 million in FY2024 (-15.4%), $25.52 million in FY2023 (-16.1%), $30.41 million in FY2022 (-16.1%) and $36.26 million in FY2021 (+283.6%).
- Quarterly Liabilities and Shareholders Equity has moved between $14.87 million (fiscal Q2 2026) and $36.26 million (fiscal Q4 2021) over five years.
- The best year-over-year quarter for Liabilities and Shareholders Equity over five years was fiscal Q4 2021 (growth of 283.6%); the worst was fiscal Q2 2025 (a decline of 30.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Anixa Biosciences | 101.33 Mn | 100.06 Mn | - | 15.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 15.07 Mn |
| Apr 30, 2026 | 14.87 Mn |
| Oct 31, 2025 | 16.08 Mn |
| Jul 31, 2025 | 17.65 Mn |
| Apr 30, 2025 | 16.98 Mn |
| Jan 31, 2025 | 18.91 Mn |
| Oct 31, 2024 | 21.59 Mn |
| Jul 31, 2024 | 22.91 Mn |
| Apr 30, 2024 | 24.36 Mn |
| Jan 31, 2024 | 25.37 Mn |
| Oct 31, 2023 | 25.52 Mn |
| Jul 31, 2023 | 26.58 Mn |
| Apr 30, 2023 | 27.60 Mn |
| Jan 31, 2023 | 28.31 Mn |
| Oct 31, 2022 | 30.41 Mn |
| Jul 31, 2022 | 32.56 Mn |
| Apr 30, 2022 | 32.80 Mn |
| Jan 31, 2022 | 35.24 Mn |
| Oct 31, 2021 | 36.26 Mn |
| Jul 31, 2021 | 37.06 Mn |
API Access
Anixa Biosciences Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ANIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "ANIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ANIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();